10X Genomics Inc expected to post a loss of 50 cents a share - Earnings Preview

10x Genomics

26/04/2024 22:51

* 10X Genomics Inc  TXG.OQ   TXG.O  is expected to show a
rise in
quarterly revenue when it reports  results on April 30 for the
period ending March 31 2024
    * The Pleasanton California-based  company is expected to
report a
5.9% increase in revenue to $142.245 million from $134.29
million a year ago, according to the mean estimate from 13
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for 10X Genomics Inc is for
a loss
of 50 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months. ​
    * Wall Street's median 12-month price target for 10X
Genomics Inc
is $56.00​, above​ its last closing price of $26.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.36       -0.36      -0.41     Missed  -14.4
 Sep. 30 2023  -0.46       -0.46      -0.79     Missed  -71.9
 Jun. 30 2023  -0.41       -0.40      -0.53     Missed  -31.3​
 Mar. 31 2023  -0.35       -0.37      -0.44     Missed  -17.7
 ​​Dec.        -0.30       -0.31      -0.15     Beat    51.9
 31 2022                                                
 Sep. 30 2022  -0.47       -0.46      -0.37     Beat    20.3​
 Jun. 30 2022  -0.40       -0.39      -0.57     Missed  -46.9
 Mar. 31 2022  -0.33       -0.31      -0.38     Missed  -21.5
 This summary was machine generated April 26 at 21:51 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)